PEDIATRICS Vol. 76 No. 1 July 1985, pp. 136-137
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation

Home Phototherapy

Committee on Fetus and Newborn

Equipment designed for delivering phototherapy in the home has become available in several parts of the United States in the past few years. Home phototherapy for neonatal hyperbilirubinemia has been suggested as an alternative means of providing care for selected infants while saving much of the cost of continued or added hospitalization. Not enough information is available presently, however, on the safety or efficacy of home phototherapy as compared with alternatives to warrant an endorsement of this form of therapy.

This statement provides preliminary guidelines for physicians who might choose home phototherapy for their patients. No attempt is made here to address the pros and cons of phototherapy per se or to define types of equipment.

A physician who considers the use of home phototherapy should limit its use to infants with the following characteristics: (1) term infants, older than 48 hours, otherwise healthy; (2) serum bilirubin concentration greater than 14 mg/dL but less than 18 mg/dL; (3) no elevation in direct-reacting bilirubin concentration; and (4) diagnostic evaluation (described below) negative.

Prior to therapy, a diagnostic evaluation should include: (1) history and physical examination; (2) hemoglobin concentration or hematocrit; (3) WBC count and differential count; (4) blood smear for red cell morphology platelets; (5) reticulocyte count; (6) total and direct-reacting bilirubin concentration; (7) maternal and infant blood typing and Coombs test; and (8) urinalysis including a test for reducing substances.

The physician should estimate the rate of rise of the serum bilirubin concentration with laboratory determinations at least four hours apart before home phototherapy is initiated.




This article has been cited by other articles:


Home page
 Home Health Care Management PracticeHome page
B. N. Murphy and R. Welch
Home phototherapy for the jaundiced full-term newborn
Home Health Care Management Practice, January 1, 1993; 5(1): 26 - 33.
[Abstract] [PDF]

Home page
 CLIN PEDIATRHome page
A. J. Schuman and G. Karush
Fiberoptic vs Conventional Home Phototherapy for Neonatal Hyperbilirubinemia
Clinical Pediatrics, June 1, 1992; 31(6): 345 - 352.
[Abstract] [PDF]

Home page
 CLIN PEDIATRHome page
B. E. Grabert, C. Wardwell, and S. K. Harburg
Home Phototherapy: An Alternative to Prolonged Hospitalization of the Full- Term, Well Newborn
Clinical Pediatrics, June 1, 1986; 25(6): 291 - 294.
[Abstract] [PDF]

Home page
 CLIN PEDIATRHome page
A. G. Rogerson, E. R. Grossman, H. S. Gruber, R. C. Boynton, and J. G. Cuthbertson
14 Years of Experience with Home Phototherapy
Clinical Pediatrics, June 1, 1986; 25(6): 296 - 299.
[Abstract] [PDF]

Home page
 CLIN PEDIATRHome page
D. K. Stevenson
Home Phototherapy: Risks Versus Benefits
Clinical Pediatrics, June 1, 1986; 25(6): 300 - 302.
[PDF]